Stephen Wilton
Vermogen: 75 540 $ op 31-05-2026
Vermogen: 75 540 $ op 31-05-2026
Stephen Wilton is currently an Independent Director at BioSyent, Inc. since 2014.
Formerly, Mr. Wilton was Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
Education includes an undergraduate degree from the University of Toronto and an MBA from The Schulich School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOSYENT INC. 0,06% | 24-03-2026 | 7.435 ( 0,06% ) | 75 540 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSYENT INC. | Directeur/Bestuurslid | 16-01-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01-01-2012 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
BioSyent, Inc.
BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
The Canadian Association of Chain Drug Stores | |
The Schulich School of Business
The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau